The Medicines Control Authority of Zimbabwe (MCAZ) has halted the use of medicines containing the pholcodine substance after learning it causes life threatening adverse reactions. By Kuda Pembere In a statement, MCAZ Director General Mr Richard Rukwata said they found that use of pholcodine a year before general anasthesia had high risk of getting anaphylactic reactions. Available data indicated that the use of pholcodine in the twelve (12) months before general anesthesia with neuromuscular blocking agents (NMBA) such as suxamethonium, and atracurium is a risk factor for developing an anaphylactic…
Read MoreZimbabwe Suspends Use Of Pholcodine Cough Medicines Use
